Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZARNESTRA and Radiation Therapy in Glioblastoma Multiforme
NCT00209989Phase 2Completed
- Sponsor
- Institut Claudius Regaud
- Start
- Oct 2005
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tipifarnib in glioblastoma multiforme (GBM), sponsored by Institut Claudius Regaud. Started Oct 2005; status: completed.
02
Drugs
tipifarnib
03
Conditions
glioblastoma multiforme (GBM)
Beyond the preview
Go deeper on NCT00209989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00209989.